Related references
Note: Only part of the references are listed.Long-term response to cabergoline and multi-modal treatment in men with macroprolactinoma: Does size really matter?
Yaron Rudman et al.
CLINICAL ENDOCRINOLOGY (2021)
Surgery as a Viable Alternative First-Line Treatment for Prolactinoma Patients. A Systematic Review and Meta-Analysis
Amir H. Zamanipoor Najafabadi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)
Prolactinomas in males: any differences?
Hadar Duskin-Bitan et al.
PITUITARY (2020)
Clinical Features, Therapeutic Trends, and Outcome of Giant Prolactinomas: A Single-Center Experience Over a 12-Year Period
Mussa H. Almalki et al.
CLINICAL MEDICINE INSIGHTS-ENDOCRINOLOGY AND DIABETES (2020)
MANAGEMENT AND OUTCOMES OF GIANT PROLACTINOMA: A SERIES OF 71 PATIENTS
Oksana Hamidi et al.
ENDOCRINE PRACTICE (2019)
Treatment of aggressive pituitary tumours and carcinomas: results of a European Society of Endocrinology (ESE) survey 2016
Ann McCormack et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2018)
The Chance of Permanent Cure for Micro- and Macroprolactinomas, Medication or Surgery? A Systematic Review and Meta-Analysis
Qianquan Ma et al.
FRONTIERS IN ENDOCRINOLOGY (2018)
Incidence and prevalence of clinically relevant pituitary adenomas: retrospective cohort study in a Health Management Organization in Buenos Aires, Argentina
Patricia Fainstein Day et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2016)
Giant prolactinomas: are they really different from ordinary macroprolactinomas?
Etual Espinosa et al.
ENDOCRINE (2016)
Retrospective comparison of cabergoline and bromocriptine effects in hyperprolactinemia: a single center experience
A. Arduc et al.
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2015)
Diagnosis and Treatment of Hyperprolactinemia: An Endocrine Society Clinical Practice Guideline
Shlomo Melmed et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cabergoline versus bromocriptine in the treatment of hyperprolactinemia: a systematic review of randomized controlled trials and meta-analysis
Vania dos Santos Nunes et al.
PITUITARY (2011)
Estimated Age- and Sex-Specific Incidence and Prevalence of Dopamine Agonist-Treated Hyperprolactinemia
M. Kars et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
Advances in the treatment of prolactinomas
Mary P. Gillam et al.
ENDOCRINE REVIEWS (2006)
Prolactin-secreting tumors: what's new?
Mark E. Molitch
EXPERT REVIEW OF ANTICANCER THERAPY (2006)
Share Paper
